Minita Patel1, Megan O Schimpf, David M O'Sullivan, Christine A LaSala. 1. Division of Urogynecology, Department of Obstetrics and Gynecology, University of Connecticut School of Medicine, Hartford Hospital, Hartford, CT 06106, USA. mpatel@harthosp.org
Abstract
OBJECTIVE: The objective of the study was to compare time to first bowel movement (BM) after surgery in subjects randomized to placebo or senna with docusate. STUDY DESIGN:Ninety-six subjects completed a baseline 7-day bowel diary before and after surgery. After pelvic reconstructive surgery, the subjects were randomized to either placebo (n=45) or senna (8.6 mg) with docusate (50 mg) (n=48). Time to first BM and postoperative use of magnesium citrate were compared. RESULTS: There was a significant difference in the time to first BM in those receiving senna with docusate vs placebo (3.00+/-1.50 vs 4.05+/-1.50 days; P<.002). More subjects in the placebo group needed to use magnesium citrate to initiate a bowel movement (43.6% vs 7.0%; P<.001). CONCLUSION: The use of senna with docusate decreases time to first BM in those undergoing pelvic reconstructive surgery compared with placebo. Subjects using senna with docusate are also significantly less likely to use magnesium citrate. Copyright (c) 2010 Mosby, Inc. All rights reserved.
RCT Entities:
OBJECTIVE: The objective of the study was to compare time to first bowel movement (BM) after surgery in subjects randomized to placebo or senna with docusate. STUDY DESIGN: Ninety-six subjects completed a baseline 7-day bowel diary before and after surgery. After pelvic reconstructive surgery, the subjects were randomized to either placebo (n=45) or senna (8.6 mg) with docusate (50 mg) (n=48). Time to first BM and postoperative use of magnesium citrate were compared. RESULTS: There was a significant difference in the time to first BM in those receiving senna with docusate vs placebo (3.00+/-1.50 vs 4.05+/-1.50 days; P<.002). More subjects in the placebo group needed to use magnesium citrate to initiate a bowel movement (43.6% vs 7.0%; P<.001). CONCLUSION: The use of senna with docusate decreases time to first BM in those undergoing pelvic reconstructive surgery compared with placebo. Subjects using senna with docusate are also significantly less likely to use magnesium citrate. Copyright (c) 2010 Mosby, Inc. All rights reserved.
Authors: Miles Murphy; Cedric Olivera; Thomas Wheeler; Elizabeth Casiano; Nazema Siddiqui; Rajiv Gala; Tondalaya Gamble; Ethan M Balk; Vivian W Sung Journal: Int Urogynecol J Date: 2012-08-08 Impact factor: 2.894
Authors: Alicia Ballard; Candace Parker-Autry; Chee Paul Lin; Alayne D Markland; David R Ellington; Holly E Richter Journal: Int Urogynecol J Date: 2015-02-12 Impact factor: 2.894
Authors: Mohammed M Alshehri; Cristina Quispe; Jesús Herrera-Bravo; Javad Sharifi-Rad; Sena Tutuncu; Elif Feyza Aydar; Cansu Topkaya; Zehra Mertdinc; Beraat Ozcelik; Mahima Aital; N V Anil Kumar; Natallia Lapava; Jovana Rajkovic; Andrea Ertani; Silvana Nicola; Prabhakar Semwal; Sakshi Painuli; Carlos González-Contreras; Miquel Martorell; Monica Butnariu; Iulia Cristina Bagiu; Radu Vasile Bagiu; Mrunal D Barbhai; Manoj Kumar; Sevgi Durna Daştan; Daniela Calina; William C Cho Journal: Oxid Med Cell Longev Date: 2022-02-04 Impact factor: 6.543